# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-23-036914
Filing Date
2023-02-14
Accepted
2023-02-14 06:12:16
Documents
39
Period of Report
2023-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d430763d8k.htm iXBRL | 8-K | 26962
2 | EX-99.1 | d430763dex991.htm | EX-99.1 | 32791
6 | GRAPHIC | g430763ex99_1s10g1.jpg | GRAPHIC | 432536
7 | GRAPHIC | g430763ex99_1s11g1.jpg | GRAPHIC | 451145
8 | GRAPHIC | g430763ex99_1s12g1.jpg | GRAPHIC | 436534
9 | GRAPHIC | g430763ex99_1s13g1.jpg | GRAPHIC | 297841
10 | GRAPHIC | g430763ex99_1s14g1.jpg | GRAPHIC | 337162
11 | GRAPHIC | g430763ex99_1s15g1.jpg | GRAPHIC | 597874
12 | GRAPHIC | g430763ex99_1s16g1.jpg | GRAPHIC | 350898
13 | GRAPHIC | g430763ex99_1s17g1.jpg | GRAPHIC | 303577
14 | GRAPHIC | g430763ex99_1s18g1.jpg | GRAPHIC | 394231
15 | GRAPHIC | g430763ex99_1s19g1.jpg | GRAPHIC | 300851
16 | GRAPHIC | g430763ex99_1s1g1.jpg | GRAPHIC | 500195
17 | GRAPHIC | g430763ex99_1s20g1.jpg | GRAPHIC | 335371
18 | GRAPHIC | g430763ex99_1s21g1.jpg | GRAPHIC | 430589
19 | GRAPHIC | g430763ex99_1s22g1.jpg | GRAPHIC | 226854
20 | GRAPHIC | g430763ex99_1s23g1.jpg | GRAPHIC | 315583
21 | GRAPHIC | g430763ex99_1s24g1.jpg | GRAPHIC | 251327
22 | GRAPHIC | g430763ex99_1s25g1.jpg | GRAPHIC | 348420
23 | GRAPHIC | g430763ex99_1s26g1.jpg | GRAPHIC | 304883
24 | GRAPHIC | g430763ex99_1s2g1.jpg | GRAPHIC | 468978
25 | GRAPHIC | g430763ex99_1s3g1.jpg | GRAPHIC | 418525
26 | GRAPHIC | g430763ex99_1s4g1.jpg | GRAPHIC | 483402
27 | GRAPHIC | g430763ex99_1s5g1.jpg | GRAPHIC | 362001
28 | GRAPHIC | g430763ex99_1s6g1.jpg | GRAPHIC | 419523
29 | GRAPHIC | g430763ex99_1s7g1.jpg | GRAPHIC | 400160
30 | GRAPHIC | g430763ex99_1s8g1.jpg | GRAPHIC | 426253
31 | GRAPHIC | g430763ex99_1s9g1.jpg | GRAPHIC | 497495
| Complete submission text file | 0001193125-23-036914.txt |  | 14103285

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | spry-20230214.xsd | EX-101.SCH | 2853
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | spry-20230214_lab.xml | EX-101.LAB | 18737
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | spry-20230214_pre.xml | EX-101.PRE | 11709
33 | EXTRACTED XBRL INSTANCE DOCUMENT | d430763d8k_htm.xml | XML | 3474

Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 23621877
SIC: 2834 Pharmaceutical Preparations